Cardiff Oncology, Inc. CRDF
NASDAQ · United States · Health Technology
$1.12-0.06 (-5.08%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -0.14 | -0.12 | -17.0% | $104.00K | +65.7% | -3.9%$1.03→$0.99 |
| Q1 2026 | 2026-05-14 | -0.18 | -0.12 | -50.0% | — | — | -1.2%$1.69→$1.67 |
| Q4 2025 | 2026-02-24 | -0.11 | -0.20 | +45.0% | — | — | +22.4%$1.56→$1.91 |
| Q3 2025 | 2025-11-06 | -0.17 | -0.21 | +19.0% | — | — | -2.2%$2.24→$2.19 |
| Q2 2025 | 2025-07-29 | -0.21 | -0.20 | -5.0% | — | — | — |
| Q1 2025 | 2025-05-08 | -0.20 | -0.19 | -5.3% | — | — | — |
| Q4 2024 | 2025-02-27 | -0.21 | -0.25 | +16.0% | — | — | — |
| Q3 2024 | 2024-11-07 | -0.25 | -0.27 | +7.4% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.